Massimo Doris, CEO of Banca Mediolanum buys 2% of the share package, creating a partnership with the company specializing in the production of new biomaterials derived from hyaluronic acid.
BMG Pharma: leadership in the Oral Care and Aesthetic Medicine sector
The double soul of BMG Pharma and our future challenges